At Manningham Medical Centre, you can find all the data about Cook Medical Zilver Ptx. We have collected data about general practitioners, medical and surgical specialists, dental, pharmacy and more. Please see the links below for the information you need.


Zilver® PTX® Drug-Eluting Peripheral Stent | Cook Medical

    https://www.cookmedical.com/products/224e3666-308f-4244-8695-6fd23bbd671c/
    Handle of the Zilver PTX delivery system Zilver PTX Drug-Eluting Peripheral Stent Indicated for improving luminal diameter for the treatment of de novo or restenotic symptomatic lesions in native vascular disease …

Zilver PTX | Cook Medical

    https://www.cookmedical.com/peripheral-intervention/zilver-ptx/
    Zilver PTX is the only SFA DES with a fully transparent 5-year safety profile. For some, controversies surrounding the use of paclitaxel-coated devices to treat PAD in the SFA …

Zilver® PTX® Drug-Eluting Peripheral Stent | Cook Medical

    https://www.cookmedical.eu/products/8193613d-2893-48c6-ac68-d64d8ac68208/
    Zilver® PTX® Drug-Eluting Peripheral Stent. Used in the treatment of …

Cook Medical’s Zilver® PTX® Earns FDA Approval As …

    https://www.cookmedical.com/newsroom/cook-medicals-zilver-ptx-earns-fda-approval-as-first-drug-eluting-stent-in-u-s-to-treat-peripheral-arterial-disease/
    The Zilver PTX Drug-Eluting Stent is intended to treat peripheral arterial disease (PAD) in the superficial femoral artery (SFA). In order to supply as many physicians as possible with this new technology, …

Zilver 635® Vascular Self-Expanding Stent | Cook Medical

    https://www.cookmedical.com/products/di_ziv_635_webds/
    Zilver 635® Vascular Self-Expanding Stent. Used as an …

Cook Medical’s Zilver® PTX® trial shows sustained …

    https://www.cookmedical.com/newsroom/cook-medicals-zilver-ptx-trial-shows-sustained-patency-after-three-years/
    Las Vegas, Nevada — Three-year data from the Zilver® PTX® Randomized Controlled Trial of Paclitaxel-Eluting Stents for Femoropopliteal Disease from Cook …

New Zilver® PTX® global data analysis reveals long

    https://www.cookmedical.com/newsroom/new-results-from-2400-zilver-ptx-patients/
    Bloomington, Ind. – Cook Medical introduced the results from an aggregated data analysis at the Vascular Interventional Advances (VIVA) conference, highlighting the Zilver ® PTX ® Drug-Eluting Peripheral Stent …

Cook Medical’s Zilver® PTX® trial shows sustained patency after …

    https://www.cookmedical.eu/newsroom/cook-medicals-zilver-ptx-trial-shows-sustained-patency-after-three-years/
    Las Vegas, Nevada — Three-year data from the Zilver® PTX® Randomized Controlled Trial of Paclitaxel-Eluting Stents for Femoropopliteal Disease from Cook Medical demonstrate …

CIRSE conference highlights patient outcomes with Zilver® …

    https://apac.cookmedical.com/prediction-model-presented-at-cirse-conference-highlights-transparency-in-patient-outcomes-with-zilver-ptx/
    The model includes data generated from more than 2,200 patients and provides increased transparency regarding the effects that patients and physicians can expect when using …

Zilver® PTX® with thumbwheel delivery system …

    https://www.cookmedical.eu/newsroom/zilver-ptx-with-thumbwheel-delivery-system-launched-in-france/
    Limerick, Ireland— Cook Medical launches Zilver® PTX® drug-eluting peripheral stent thumbwheel delivery system in France. The French Health Ministry has now approved reimbursement for the Zilver PTX …



Need more information about Cook Medical Zilver Ptx?

At Manningham Medical Centre, we collected data on more than just Cook Medical Zilver Ptx. There is a lot of other useful information. Visit the related pages or our most popular pages. Also check out our Doctors page.